← Back to Alzheimer's Drug Discovery Foundation Profile
What type of founders does Alzheimer's Drug Discovery Foundation target?
Alzheimer's Drug Discovery Foundation targets researchers and biotech companies focused on Alzheimer's drug discovery.
The Alzheimer's Drug Discovery Foundation (ADDF) is a venture philanthropy organization dedicated to funding breakthrough research in academia and the biotech industry to find drugs for Alzheimer's disease. Founded in 1998 by Leonard A. and Ronald S. Lauder, the ADDF has awarded nearly $400 million to fund 792 Alzheimer's drug development, biomarker, and prevention programs in 21 countries.
- Founded in 1998 by Leonard A. and Ronald S. Lauder
- Awarded nearly $400 million in funding
- Funded 792 Alzheimer's drug development programs
- Operates in 21 countries
More Questions About Alzheimer's Drug Discovery Foundation
- What is Alzheimer's Drug Discovery Foundation?
The Alzheimer's Drug Discovery Foundation (ADDF) is a venture philanthropy organization dedicated to funding breakthrough research in academia and the biotech industry to find drugs for Alzheimer's disease.
- Where is Alzheimer's Drug Discovery Foundation located?
The Alzheimer's Drug Discovery Foundation is located in New York, USA.
- When was Alzheimer's Drug Discovery Foundation founded?
The founding date of Alzheimer's Drug Discovery Foundation is not publicly available.
- What type of investor is Alzheimer's Drug Discovery Foundation?
Alzheimer's Drug Discovery Foundation is a venture capital firm.
- Does Alzheimer's Drug Discovery Foundation invest in Biotechnology?
Yes, Alzheimer's Drug Discovery Foundation invests in Biotechnology.
- Does Alzheimer's Drug Discovery Foundation invest in Pharmaceuticals?
Yes, Alzheimer's Drug Discovery Foundation invests in Pharmaceuticals.
Verification Confidence: 92% | Source: investment_thesis | Entity: Alzheimer's Drug Discovery Foundation